• Merck announced that it is working with Chinese regulators to explore the possibility of bringing molunpiravir, an oral antiviral used for mild-to-moderate COVID during the first five days after symptom onset. The drug, which has been approved in the UK, is currently under review by regulators in the EU and the US. Source
• The Denver Zoo reports the first worldwide cases of SARS-CoV-2 in two spotted hyenas, who have mild symptoms, 22-year-old Ngozi and 23-year-old Kibo, as well as 11 lions and two tigers – who are now fully recovered. Source
• Sinovac says its coronavirus vaccine is safe and effective for babies as young as six months; it has submitted data to regulators in Hong Kong from phase I and II trials and a mass immunization program in children ages 3 to 17 years, which focused on safety and immune responses. The company is currently working on a next-generation coronavirus vaccine. Source